Results 101 to 110 of about 178,280 (162)

Clinical case report: combination of endocrine ophthalmopathy and myasthenia gravis: diagnostic and therapeutic difficulties [PDF]

Клиническая офтальмология
D.S. Atarshchikov1, E.S. Taskina2, D.P. Podkopaeva3, N.I. Kibalina1 1AO GK Medsi, Moscow, Russian Federation 2Chita State Medical Academy, Chita, Russian Federation 3I.M.
D.S. Atarshchikov, E.S. Taskina, D.P. Podkopaeva, N.I. Kibalina   +3 more
doaj  

Unilateral Proptosis Caused by Ocular Myasthenia Gravis

, 2011
Proptosis is a little-recognized finding in ocular myasthenia gravis, except when attributed to coexistent thyroid ophthalmopathy.
J. Alexander Fraser; Michael W. Nicolle; David A. Nicolle
core  

Prevalence of Thymoma in Ocular Myasthenia Gravis (.pdf)

, 2016
The prevalence of thymoma in ocular myasthenia gravis has not been explicitly investigated in the medical literature. Published data vary and chiefly consist of smaller case series. The purpose of this study is to determine the prevalence of thymoma in a
Anthony J. Brune; Lina Nagia; Joao Lemos; Lindsey B. De Lott; Khawla Abusamra; Wayne T. Cornblath; Eric R. Eggenberger
core  

Mycophenolate Mofetil (Cellcept) 10 Ocular Myasthenia Gravis

, 2008
Immunosuppressive therapies (e.g., corticosteroids, azathioprine, eydosporine) have been used in ocular myasthenia gravis (OMG). Unfortunately effectiveness is limited by their variable efficacy, side effects and patient rolerana.
Aileen Antonio-Santos; Eric Eggenberger; Umar Farooq; Richard Freij
core  

Familial Myasthenia Gravis

, 1982
Unilateral Ptosis; External OphthalmoplegiaOcular Myasthenia Gravis: Past, Present and Future: https://collections.lib.utah.edu/details?id=2174219Droopy eyelidsIn 1999 Dr. A. G.
Shirley H. Wray, MD, PhD, FRCP
core  

Ocular Motor Dysfunction in Ocular Myasthenia Gravis: Effects of Treatment

, 2005
The optimal treatment of the ophthalmoparesis associated with ocular myasthenia gravis (OMG) remains unknown. We evaluated the efficacy of prednisone and pyridostigmine in reducing diplopia and ocular motor dysfunction in patients with ...
Mark J. Kupersmith; Gui-shuang Ying
core  

Miastenia grave y miastenia grave ocular

Revista Cubana de Oftalmología
La miastenia grave es una enfermedad caracterizada por debilidad y fatiga de los músculos voluntarios debido a una trasmisión anómala a nivel de la unión neuromuscular. La prevalencia es aproximadamente de 5 casos/100 000 personas.
Rosa María Naranjo Fernández, Yaimir Estévez Miranda, Teresita de Jesús Méndez Sánchez, Milagros D Dorrego Oduardo, Raúl Rúa Martínez   +4 more
doaj  

Myasthenia Gravis: Recent Developments

, 2005
To: 1. Describe the potential mechanisms for preferential involvement of ocular muscles by myasthenia gravis; 2. Discuss risks and benefits of corticosteroid use for treatment of ocular myasthenia; 3. Appropriately use edrophonium, serum autoantibody and
Henry J. Kaminski, MD
core  

Clinical research on ocular myasthenia gravis and related neuromuscular disorders: A systematic review and overview

Background: Ocular myasthenia gravis is an acquired autoimmune disorder primarily manifesting clinically as ptosis, diplopia, ocular muscle paralysis, and restricted ocular motility.
ZhaoYuan Sheng, MengYu Wang
core   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Ocular myasthenia gravis

S.S. Korsakov Journal of Neurology and Psychiatry, 2023
The article describes an urgent medical and social problem — the diagnosis and treatment of the ocular myasthenia gravis. Despite recent advances in the study of synaptic pathology, the diagnosis of the ocular form of myasthenia gravis remains a challenging problem. This is due to the poor information content of laboratory and electromyographic methods
A.G. Sanadze, D.V. Sidnev, D.A. Tumurov, O.I. Afanasieva   +3 more
  +6 more sources